ONINTZA
SAGREDO EZQUIOGA
Profesora titular de universidad
Fundación Hospital Alcorcón
Alcorcón, EspañaPublicaciones en colaboración con investigadores/as de Fundación Hospital Alcorcón (6)
2016
-
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
Journal of Neurology, Vol. 263, Núm. 7, pp. 1390-1400
2014
-
A restricted population of CB1 cannabinoid receptors with neuroprotective activity
Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 22, pp. 8257-8262
2011
-
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease
Brain, Vol. 134, Núm. 1, pp. 119-136
2009
-
Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
GLIA, Vol. 57, Núm. 11, pp. 1154-1167
-
Lack of association between polymorphisms in cannabinoid receptor gene (CNR1) and fatty acid amide hydroxylase gene (FAAH) and eating disorders in a preliminary study
Psychiatric Genetics, Vol. 19, Núm. 6, pp. 336
-
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
Brain, Vol. 132, Núm. 11, pp. 3152-3164